*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>CARNITINE isomer impurity refers to non-target stereoisomers (e.g., L-carnitine vs. D-carnitine) found during <strong>L-carnitine</strong> synthesis. These byproducts arise from incomplete enzymatic resolution or chemical racemization, necessitating rigorous purification via chiral chromatography.</p>
<h3>Application</h3>
<ul>
<li><strong>Pharmaceutical QC:</strong> Serving as reference standards for purity analysis in drug substance certification.</li>
<li><strong>R&D:</strong> Used to optimize synthetic pathways and evaluate catalyst selectivity.</li>
<li><strong>Regulatory Compliance:</strong> Supporting ICH guideline documentation for impurity profiling.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly store under <strong>-20°C</strong> in desiccated conditions to prevent degradation. Handle with appropriate PPE; avoid inhalation of dust. Not intended for direct clinical use due to potential biological inactivity or toxicity compared to the active enantiomer.</p>